These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21959817)

  • 1. Development of meloxicam formulations utilizing ternary complexation for solubility enhancement.
    Awasthi SS; Kumar TG; Manisha P; Preeti Y; Kumar SS
    Pak J Pharm Sci; 2011 Oct; 24(4):533-8. PubMed ID: 21959817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.
    Agarwal V; Alayoubi A; Siddiqui A; Nazzal S
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1681-9. PubMed ID: 23072611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
    Ghorab MM; Abdel-Salam HM; El-Sayad MA; Mekhel MM
    AAPS PharmSciTech; 2004 Jul; 5(4):e59. PubMed ID: 15760056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
    Radia O; Rogalska E; Moulay-Hassane G
    Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS; Vavia PR
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
    Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
    Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK; Gaud RS; Bakal R; Patil D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meloxicam β-cyclodextrin transdermal gel: physicochemical characterization and in vitro dissolution and diffusion studies.
    Rasool BK; Gareeb RH; Fahmy SA; Rasool AA
    Curr Drug Deliv; 2011 Jul; 8(4):381-91. PubMed ID: 21453259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
    El-Maradny HA; Mortada SA; Kamel OA; Hikal AH
    Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes.
    Cao F; Guo J; Ping Q
    Drug Dev Ind Pharm; 2005 Sep; 31(8):747-56. PubMed ID: 16221609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
    Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
    Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug.
    Comoglu T; Unal B
    Pharm Dev Technol; 2015 Jan; 20(1):60-4. PubMed ID: 24295202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose.
    Jug M; Bećirević-Laćan M
    Drug Dev Ind Pharm; 2004; 30(10):1051-60. PubMed ID: 15595571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.